January 2009 in “Springer eBooks” The document concludes that managing skin conditions during pregnancy is important and requires specialized care.
54 citations
,
April 2007 in “Gastroentérologie clinique et biologique” This review highlights that bariatric surgery can increase nutritional deficiencies in morbidly obese patients, with particular emphasis on the risks of deficiency due to reduced food intake and malabsorption.
16 citations
,
May 2019 in “International Journal of Women's Dermatology” This study reviewed and categorized dermatological drugs for pregnancy and lactation according to new FDA labeling guidelines, which replaced simplistic letter categories with detailed information, aiming to improve prescribing decisions by addressing both maternal and paternal reproductive potential.
October 2025 in “BENTHAM SCIENCE PUBLISHERS eBooks” This chapter explores the potential benefits of using easily available herbal ingredients in hair care formulations, suggesting they offer therapeutic benefits with reduced side effects for various hair issues like dandruff and hair fall, especially in sensitive populations.
June 2021 in “International Journal of Research in Dermatology” This study found that one-third of females with acne and PCOS also showed insulin resistance, suggesting that women with these conditions should be evaluated for impaired glucose tolerance.
724 citations
,
April 2004 in “Lancet Oncology” This review summarizes the use and neonatal outcomes of chemotherapy during pregnancy, noting its potential for safe use in the second and third trimesters, and reports no new clinical results.
141 citations
,
January 1984 in “Journal of The American Academy of Dermatology” This review discusses skin changes during pregnancy, highlighting both pregnancy-specific and common physiologic changes, but reports no new clinical findings.
87 citations
,
July 2012 in “Expert Review of Clinical Immunology” This review outlines pregnancy risks in systemic lupus erythematosus and emphasizes that active lupus nephritis at conception increases the risk of flares and poor obstetric outcomes; it reports no new clinical findings.
47 citations
,
May 2002 in “Journal of Cutaneous Medicine and Surgery” This review discusses normal skin changes during pregnancy such as pigmentary and glandular alterations, highlighting the need for physician awareness to avoid unnecessary treatments, and reports no new clinical findings.
29 citations
,
December 2012 in “Current Opinion in Endocrinology, Diabetes and Obesity” This review discusses factors affecting fertility in both men and women with congenital adrenal hyperplasia and emphasizes individualized preconception management but reports no new clinical results.
1 citations
,
January 2000 in “Springer eBooks” This review discusses the evaluation of skin conditions during pregnancy and emphasizes the importance of testing for syphilis, but it reports no new clinical results.
November 2024 in “Rheumatology Advances in Practice” In this case report, the use of ocrelizumab in the second trimester of a high-risk pregnancy with active juvenile-onset systemic lupus erythematosus resulted in a successful birth without complications, although its safety in pregnancy remains unlicensed and further evaluation is needed.
March 2022 in “Journal of Pakistan Association of Dermatologists” This case report describes a pregnant woman with pemphigus vulgaris whose condition improved with systemic corticosteroid treatment, highlighting the challenges of managing PV during pregnancy and the importance of intensive monitoring.
November 2021 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” This article describes a case of pruritic folliculitis of pregnancy, a rare, benign skin condition that occurs in the later stages of pregnancy and resolves after delivery without affecting maternal or fetal health.
180 citations
,
October 2019 in “British journal of haematology” These guidelines provide updated recommendations for healthcare professionals on preventing, diagnosing, and treating iron deficiency in pregnant and postpartum women in the UK, acknowledging the lack of high-quality evidence for many current practices.
9 citations
,
January 2017 in “Journal of Clinical and Diagnostic Research” This article reviews the skin changes during pregnancy, categorizing them by their relation to pregnancy and highlighting cosmetic concerns, but reports no new results.
January 2026 in “Scholars Journal of Medical Case Reports” This article outlines a diagnostic and treatment approach for polycystic ovarian syndrome in young women, emphasizing lifestyle modifications, hormonal treatments, and specialist referrals for managing symptoms and fertility concerns.
2 citations
,
November 1995 in “American Journal of Obstetrics and Gynecology” This article reviews the need for multicenter clinical trials to establish reference data for ultrasound screening protocols for Down syndrome and reports no new findings.
July 2019 in “International journal of reproduction, contraception, obstetrics and gynecology” This study concluded that women with obesity have a higher risk of developing polycystic ovarian syndrome compared to those without obesity.
March 2024 in “Post-Graduate Medical Journal of NAMS” In this study, researchers found that 20% of patients with androgenetic alopecia also had metabolic syndrome, suggesting a notable prevalence similar to other studies conducted in similar settings.
2 citations
,
January 2019 in “Biomedical Journal of Scientific and Technical Research” This article describes the growth and characteristics of saw palmetto and its fruit but reports no new research results.
December 2011 in “The Diabetes Educator” This article describes how a new blood glucose management service at the NIH Clinical Center improved safety and patient outcomes for hospitalized patients with diabetes.
February 2024 in “Endocrinology and Disorders” This article compiles evidence on prescribing estrogen for hormonal imbalance in women, emphasizing it should be personalized and carefully managed by healthcare providers based on individual cases.
3 citations
,
February 2016 in “Endocrinology and Metabolism Clinics of North America” This review discusses the timing and management of dyslipidemia screening and intervention in pregnancy and highlights the need for lipid profile assessments each trimester; it reports no clinical results.
98 citations
,
May 2010 in “British Journal of Dermatology” This document discusses the British Association of Dermatologists' current perspective on isotretinoin, focusing on its known side effects, prescribing requirements, teratogenic risks, and the contentious link to mood changes, reporting no new research findings.
August 2024 in “International Journal of Health Science” This narrative review found that Telogen Effluvium significantly affects women in Brazil due to its psychological impact and limited access to treatment, exacerbated by economic and healthcare disparities.
This review discusses the variety of skin changes and diseases that can occur during pregnancy, categorizing them into physiological changes, non-specific alterations, and pregnancy-specific dermatoses, and reports no clinical results.
June 2026 in “Dermatology and Skin Science” This study highlights that acne is a common issue for transgender men undergoing testosterone therapy, with management generally following similar guidelines as for cisgender individuals.
4 citations
,
March 2002 in “Journal of the American Pharmaceutical Association” This review discusses various skin conditions affecting women throughout their lives and highlights the pharmacist's role in advising on management and treatment, but it reports no new clinical results.
This study found that self-monitoring blood pressure among pregnant women with hypertension did not significantly improve clinical outcomes compared to usual care, though women reported positive cognitive and emotional responses.